Proposed £10m secondary Placing of existing Ordinary Shares
Sopheon has been advised by Barry Mence, Andy Michuda, Arif Karimjee, and Stuart Silcock (the "Directors"), along with other shareholders (together the "Selling Shareholders"), that they intend to sell approximately 1,116,486 ordinary shares of 20 pence each in the Company ("Ordinary Shares") (the "Placing Shares", the "Placing") at a price of 900 pence per share ("Placing Price") for the purposes of estate planning and to improve the liquidity in the Company's shares. The Directors who, following the Placing, will hold in aggregate c. 22.9% of the issued share capital of the Company remain very supportive long term shareholders.
The Placing Shares are being offered by way of an accelerated bookbuild, which will be launched immediately following this Announcement.
The following Directors intend to sell up to the below outlined maximum number of shares each:
Director/PDMR
Position
Maximum number of Placing Shares to be sold
Barry Mence
Chairman
356,829
Andy Michuda
Chief Executive Officer
185,036
Arif Karimjee
Chief Financial Officer
48,343
Stuart Silcock
Non-Executive Director
166,500
The other shareholders intend to sell a maximum of 359,778 shares.
The Placing is being managed by finnCap Ltd acting as sole bookrunner ("finnCap" or the "Bookrunner").
The final number of Placing Shares to be placed will be agreed by finnCap and the Selling Shareholders at the close of the bookbuild process, and the results of the Placing will be announced as soon as practicable thereafter. The timing for the close of the bookbuild process will be at the absolute discretion of finnCap.
The Company is not a party to the Placing and will not receive any proceeds from it. The books for the Placing will open with immediate effect.
Barry Mence, Chairman of Sopheon, commented: "We continue to believe that we have a substantial opportunity ahead of us and we are delighted with our continued successful migration to a SaaS subscription model on the back of Total Contract Value ("TCV") of signed SaaS business almost tripling in 2020. More broadly, we had good commercial traction with growth in total TCV signed, including several $1m deals, during a year marked by the pandemic. This has led to Annual Recurring Revenue ("ARR") growing to $18m last year, resulting in greater revenue visibility for 2021, currently standing at $23.5m. This Placing will help to provide greater liquidity in the Company's shares and meets with our long-standing objective of expanding our institutional shareholder base. "
Deze plaatsing zal bijdragen tot een grotere liquiditeit van de aandelen van het bedrijf en beantwoordt aan onze al lang bestaande doelstelling om onze institutionele aandeelhoudersbasis uit te breiden.
[